Finance

Beta
Lists
SNES:NASDAQ
SenesTech Inc
$1.61
+5.23%
(+0.080) 1D
$1.64
+1.86% (+0.030)
After hours
Closed: Jun 8, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SNES...
Open
$1.56
High
$1.64
Low
$1.55
Mkt. cap
8.54M
Avg. vol.
110.75K
Volume
0.00
52-wk high
$6.24
52-wk low
$1.41
EPS
-$1.89
Beta
0.28
Shares outstanding
5.30M
No. of employees
24
Open
$1.56
High
$1.64
Low
$1.55
Mkt. cap
8.54M
Avg. vol.
110.75K
Volume
0.00
52-wk high
$6.24
52-wk low
$1.41
EPS
-$1.89
Beta
0.28
Shares outstanding
5.30M
No. of employees
24
Analyst outlook
Analyst Ratings
Based on 1 analyst giving stock ratings to SNES in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12 month forecast
Based on 1 Wall Street analyst offering 12 month price targets for SNES in the last 3 months.
Highest
Current $1.61
$10.00 (+521.12%)
Average
$10.00 (+521.12%)
Lowest
$10.00 (+521.12%)
News stories
From sources across the web
Profile
SenesTech, Inc. is an agricultural biotechnology life-sciences company, specializing in fertility management as a form of pest control. The company's primary product, ContraPest is designed to make brown and black rats infertile. SenesTech is headquartered in Phoenix, Arizona. Wikipedia
About SenesTech Inc
CEOKen Siegel
Employees24
Founded2004
HeadquartersSurprise, Arizona, United States
SectorPharmaceutical industry
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
625.00K
690.00K
421.00K
493.00K
Cost of goods sold
216.00K
257.00K
188.00K
155.00K
Cost of revenue
216.00K
257.00K
188.00K
155.00K
Research and development expenses
296.00K
298.00K
349.00K
422.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.73M
1.48M
1.76M
2.04M
Operating expense
2.02M
1.78M
2.11M
2.46M
Total operating expenses
2.24M
2.04M
2.30M
2.61M
Operating income
-1.61M
-1.35M
-1.88M
-2.12M
Other non operating income
-
-
-
-
EBT including unusual items
-1.62M
-1.30M
-1.80M
-2.06M
EBT excluding unusual items
-1.62M
-1.30M
-1.80M
-2.06M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1.62M
-1.30M
-1.80M
-2.06M
Net profit margin
-258.56%
-188.12%
-428.50%
-418.46%
Earnings per share
-
-
-
-
Interest and investment income
4.00K
55.00K
82.00K
56.00K
Interest expense
-6.00K
-6.00K
-5.00K
-
Net interest expenses
-2.00K
49.00K
77.00K
56.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.58M
-1.32M
-1.85M
-2.09M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more